Shares in Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) fell 11% during trading on Thursday. The company’s shares fell to a low of 1.70 GBX ($0.02) before last trading at 1.83 GBX ($0.02). Approximately 5,180,506 shares were traded during midday trading, up 241% from the average daily trading volume of 1,518,574 shares. The stock had closed earlier at 2.05 GBX ($0.03).
Cizzle Biotech Price Performance
The company has a market capitalization of GBP 7.53 Million, a price-to-earnings ratio of -168.80 and a beta of 0.38. The company’s 50-day simple moving average is 1.79 GBX and its 200-day simple moving average is 2 GBX.
Company Profile of Cizzle Biotechnology
(Get your free report)
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, is working on developing an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the U.K. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
read more
Get Cizzle Biotechnology News and Ratings Daily – Enter your email address below to receive a concise summary of the latest news and analyst ratings on Cizzle Biotechnology and related companies every day with MarketBeat.com’s free email newsletter.
